RISK-STRATIFICATION OF THE APPARENTLY HEALTHY POPULATION USING CURRENT TOOLS
• Risk Stratification is a tool to help identify and predict patients at high-risk or potentially at high-risk of heart attacks, heart failure or death, and prioritizing their care to help prevent unfavorable outcomes.
• Current risk-stratification tools like Framingham, Euroscore and Lipid profile are not cardiac specific and can be heavily influenced by age.
RISK-STRATIFICATION OF THE APPARENTLY HEALTHY POPULATION USING ALINITY HIGH SENSITIVE TROPONIN-I
• The cardiac specific biomarker that aids in predicting future cardiac events using the unmatched power of cardiac specificity for a blood test that can be added to existing wellness check offerings.
• In conjunction with clinical and diagnostic findings, aids in earlier identification and intervention in higher risk patients to prevent cardiac events.
• Compared to existing risk-stratification tools, provides greater accuracy in identifying lower risk patients, which may avoid unnecessary investigations, treatments and potential side effects.
• Through early identification and appropriate categorization of at-risk patients,7 has the potential to reduce the growing cost burden to the healthcare system.
• Resistant to biotin interference.
THE FOLLOWING CUT-OFF USED TO AID IN STRATIFYING THE RISK OF CARDIOVASCULAR DISEASE IN ASYMPTOMATIC INDIVIDUALS:
Risk | Male (ng/L) | Female (ng/L) |
Low | <6 | <4 |
Moderate | 6 – 12 | 4 – 10 |
Elevated | >12 | >10 |
Asymptomatic individuals with elevated troponin levels are associated with a higher risk of developing cardiovascular related diseases in the future.